phase iii trial - Robuta Search

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-phase-iii-trial-of-nucala-mepolizumab-in-copd/ GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD | GSK GSK announces positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) in adults with COPD. phase iii trial https://www.sciencedaily.com/releases/2011/09/110923194732.htm Cancer treatment: First Phase III trial of an alpha-pharmaceutical shows promising results |... The first Phase III study of an alpha-pharmaceutical (Radium-223 Chloride -- Alpharadin) in patients with bone metastases from advanced prostate cancer has... phase iii trial https://www.mskcc.org/news-releases/pivotal-results-phase-iii-trial-show-combination-ipilimumab-and-nivolumab-nivolumab-alone-increase-progression-free-survival-advanced-melanoma-patients Pivotal Results from Phase III Trial Show Combination of Ipilimumab and Nivolumab or Nivolumab... Treating advanced melanoma patients with either a combination of the immunotherapy drugs nivolumab and ipilimumab or nivolumab alone significantly increases... phase iii trial https://www.gsk.com/en-gb/media/press-releases/primary-endpoint-met-in-comet-tail-phase-iii-trial-evaluating-intramuscular-administration-of-sotrovimab-for-early-treatment-of-covid-19/ Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of... Phase III IM administration data for sotrovimab. phase iii trial https://www.mdedge.com/content/belimumab-shows-effectiveness-phase-iii-trial Belimumab Shows Effectiveness in Phase III Trial | MDedge phase iii trial belimumab shows effectiveness https://www.miragenews.com/tozorakimab-hits-primary-goal-in-copd-phase-iii-1658188/ Tozorakimab Hits Primary Goal in COPD Phase III Trial | Mirage News Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically phase iii trial tozorakimab hits primary goal https://www.cincinnatichildrens.org/service/c/clinical-trials/studies/A031102 A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel,... A031102: A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy... phase iii trial https://www.biospace.com/sanofi-axes-lung-cancer-adc-after-phase-iii-failure Sanofi Axes Lung Cancer ADC After Phase III Trial Failure - BioSpace Dec 21, 2023 - The company is ending its program evaluating antibody-drug conjugate tusamitamab ravtansine after a non-small cell lung cancer trial did not meet a primary... phase iii trial lung cancer sanofi axes adc https://www.biospace.com/alnylam-indicates-that-phase-iii-trial-is-successful-thus-far Alnylam Indicates Phase III Trial Is Successful Thus Far - BioSpace Sep 27, 2018 - Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) in presently in the midst of a Phase 3 study of givosiran, reporting that the drug has been successful in a... phase iii trial thus far alnylam successful https://www.news-medical.net/news/2009/02/18/45982.aspx GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication Jun 18, 2019 - GlaxoSmithKline has announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and... phase iii trial type 2 diabetes https://www.yalemedicine.org/clinical-trials/phase-iii-trial-of-immunotherapy-based-combination-therapy-with-or-without-cytoreductive-neph Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive... This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care... phase iii trial https://www.news-medical.net/news/20150114/PharmaMar-to-begin-PM1183-Phase-III-trial-in-combination-with-doxorubicin-in-SCLC.aspx PharmaMar to begin PM1183 Phase III trial in combination with doxorubicin in SCLC Jun 19, 2019 - Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in... phase iii trial https://www.biospace.com/cytodyn-initiates-first-clinical-site-for-phase-iii-trial-of-pro-140 CytoDyn Initiates First Clinical Site For Phase III Trial Of PRO 140 - BioSpace phase iii trial https://www.prnewswire.co.uk/news-releases/photocure-partner-asieris-announces-approval-to-conduct-a-phase-iii-clinical-trial-for-hexvix-in-china-874974755.html Photocure Partner Asieris announces Approval to conduct a Phase III Clinical Trial for Hexvix in... /PRNewswire/ -- Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has obtained the Phase... https://investingnews.com/renovorx-announces-key-phase-iii-milestone-tiger-pac-trial-surpasses-100-randomized-patients-as-study-nears-completion-of-enrollment/ RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as... Mar 26, 2026 - TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027 Select TIGeR-PaC Cancer Centers Now Using... https://gulfnews.com/uae/coronavirus-recruitment-of-volunteers-for-phase-iii-vaccine-trial-to-start-in-abu-dhabi-1.1594885159109 Coronavirus: Recruitment of volunteers for Phase III vaccine trial to start in Abu Dhabi Abu Dhabi Department of Health chairman becomes the first to participate in the trial https://www.prnewswire.com/news-releases/zydus-therapeutics-reports-positive-topline-results-from-epics-iii-phase-2b3-trial-of-saroglitazar-magnesium-in-patients-with-primary-biliary-cholangitis-302542014.html Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of... /PRNewswire/ -- Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced... https://www.timeslive.co.za/news/world/2021-05-07-indias-biological-e-to-begin-phase-iii-trial-of-vaccine-production-from-august/ India's Biological E. to begin Phase III trial of vaccine, production from August India's Biological E. Ltd will soon start Phase III trials of its Covid-19 vaccine and plans producing 75 million to 80 million doses a month from August, its... https://www.novartis.com/news/novartis-provides-update-phase-iii-stand-trial-assessing-crizanlizumab Novartis provides update on Phase III STAND trial assessing crizanlizumab | Novartis phase iii novartis provides update stand https://www.elsevier.es/en-revista-revista-espanola-cirugia-ortopedica-traumatologia-429-pdf-S1988885620300031 Randomized, double-blind, controlled trial, phase III, to evaluate the use of platelet-rich plasma... https://www.news-medical.net/news/20100326/Positive-data-from-Shires-Phase-III-trial-of-TKT-034-in-Type-1-Gaucher-disease-patients-who-switched-to-VPRIV.aspx Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who... Jun 27, 2018 - Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the... https://www.gov.uk/research-for-development-outputs/prevalence-of-anaemia-in-women-at-screening-and-follow-up-in-a-microbicide-phase-iii-trial Prevalence of anaemia in women at screening and follow-up in a microbicide phase III trial. - GOV.UK https://www.roche.com/investors/updates/inv-update-2021-04-12 Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail... Among individuals who still experienced symptomatic infections, those who received casirivimab and imdevimab were able to clear the virus faster and had much... phase iii subcutaneous administration prevention trial showed https://pmc.ncbi.nlm.nih.gov/articles/PMC8172438/ Estimating the Financial Costs Associated with a Phase III, Multi-site Exercise Intervention Trial:... Supervised exercise interventions are expensive and time intensive. However, there are financial costs to consider in addition to the intervention itself,... https://investingnews.com/greenwich-lifesciences-presents-flamingo-01-phase-iii-trial-open-label-data-published-at-aacr-meeting-2026/ Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR... Apr 20, 2026 - Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,... https://www.prnewswire.com/news-releases/first-patient-dosed-in-pivotal-phase-iii-trial-of-cadonilimab-pd-1ctla-4-for-perioperative-treatment-of-resectable-gastric-cancer-302534437.html First Patient Dosed in Pivotal Phase III Trial of Cadonilimab (PD-1/CTLA-4) for Perioperative... /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the enrollment and dosing of the first patient in the pivotal Phase III clinical... https://www.prnewswire.com/news-releases/neurosigma-announces-fda-approval-to-commence-phase-iii-trial-217368281.html NeuroSigma Announces FDA Approval to Commence Phase III Trial /PRNewswire/ -- NeuroSigma, Inc., today announced conditional approval by the U.S. Food and Drug Administration (FDA) of its Investigational Device Exemption... fda approval phase iii neurosigma announces commence https://www.fhi.no/en/projects/cancer/gardasil-9-ltfu-v503/ LTFU V503: Long-Term Follow-Up of Women Participating in the Phase III Clinical Trial with the... This long-term study of the Gardasil 9 vaccine will provide information about the vaccine's safety, protection, and duration for up to 14 years after... https://www.biospace.com/jazz-pharmaceuticals-inc-announces-phase-iii-clinical-trial-to-study-the-safety-and-efficacy-of-xyrem-r-sodium-oxybate-in-patients-with-fibromyal Jazz Pharmaceuticals, Inc. Announces Phase III Clinical Trial To Study The Safety And Efficacy Of... phase iii clinical trial https://www.biospace.com/george-medicines-completes-recruitment-of-first-phase-iii-hypertension-trial-investigating-novel-single-pill-triple-combination-candidate-gmrx2 George Medicines completes recruitment of first Phase III hypertension trial investigating novel... Jul 12, 2023 - George Medicines, a late-stage drug development company transforming the management of cardiometabolic disease, today announced that all patients have been... https://www.biospace.com/basilea-pharmaceutica-s-antifungal-isavuconazole-passed-phase-iii-clinical-trial-futility-analysis Basilea Pharmaceutica's Antifungal Isavuconazole Passed Phase III Clinical Trial Futility Analysis... phase iii clinical trial basilea pharmaceutica